Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin. (Q35827938)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2006

Language	Label	Description	Also known as
English	Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin.	scientific article published in December 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

0 references

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

peginterferon alfa-2a

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Eric Snoeck

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Frank Duff

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Matthew Lamb

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Karin Jorga

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

0 references

publication date

1 December 2006

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

62

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

699-709

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885193

27 July 2018

Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885193

27 July 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885193

27 July 2018

Ribavirin Quantification in Combination Treatment of Chronic Hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885193

27 July 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885193

27 July 2018

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02741.X

21 January 2018

Review article: indicators and predictors of response to anti-viral therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02741.X

21 January 2018

Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic-pharmacodynamic models.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02741.X

21 January 2018

Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02741.X

21 January 2018

Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02741.X

21 January 2018

High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02741.X

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02741.X

21 January 2018

Dosage adjustment of ribavirin based on renal function in Japanese patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02741.X

21 January 2018

Pharmacokinetics of ribavirin in patients with hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1885193

24 September 2018

Identifiers

10.1111/J.1365-2125.2006.02741.X

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17118125%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35827938&oldid=1590413114"